Trends in Neurosciences
Volume 30, Issue 10, October 2007, Pages 527-535
Journal home page for Trends in Neurosciences

Review
Neurotransmitter receptors on microglia

https://doi.org/10.1016/j.tins.2007.07.007Get rights and content

Microglia are the intrinsic immune cells of the brain and express chemokine and cytokine receptors that interact with the peripheral immune cells. Recent studies have indicated that microglia also respond to the brain's classical signalling substances, the neurotransmitters. Here, we review the evidence for the expression of neurotransmitter receptors on microglia and the consequences of this receptor activation for microglial behaviour. It is evident that neurotransmitters instruct microglia to perform distinct types of responses, such as triggering an inflammatory cascade or acquiring a neuroprotective phenotype. Understanding how microglia respond to different neurotransmitters will thus have important implications for controlling the reactivity of these cells in acute injury, as well as for treating chronic neurodegenerative diseases.

Introduction

Microglia are present in all regions of the central nervous system (CNS), although their density varies in different brain regions [1]. Microglia, first described by Río- Hortega [2] and characterized by a small soma and several highly branched processes, are derived from the myelomonocytic lineage and invade the CNS tissue at both embryonic and postnatal stages (for reviews, see 3, 4). These microglial precursors possess an ameboid morphology and actively migrate within the brain parenchyma to colonize all regions of the brain. Microglia acquire a highly ramified morphology in the healthy adult brain; microglia in this form are termed ‘resting microglia’. [5]. When one observes the morphology of resting microglia, it is evident that each cell has a territory that it covers with its highly branched processes. Two recent reports have noted that these processes are highly motile; in fact, they are the most dynamic structures in the CNS 6, 7. This process movement could be viewed as a constant survey of the microglial cell's territory, and these cells should perhaps be termed ‘surveying’ than ‘resting’ microglia (Figure 1, Figure 2, Figure 3).

The majority of previous studies on microglia have been concerned with their role in pathology (for a review, see [3]). Microglia are the first elements to respond after any kind of disturbance in the brain. They undergo a transformation, also termed microglial activation, that can happen within a few hours and last many days. One feature of this activation process is the transformation of the cells into an ameboid morphology that is similar to that of the initial infiltrating precursors. Depending on the pathologic stimulus, the activated microglia might proliferate, migrate toward injured or damaged areas and/or be induced to release many factors, such as cytokines or reactive oxygen species (ROS), that affect the pathologic process. Microglia are antigen-presenting cells because they express proteins of the MHC-II complex and are, thereby, interaction partners with infiltrating T lymphocytes. They express a wide array of characteristic immune-cell receptors, such as chemokine and cytokine receptors and receptors of the complement-factor family. Thus, microglia have been viewed as intrinsic immune cells, but they have not been considered as normal communication partners within the neuronal network. Functional synapses have recently been discovered on subtypes of astrocytes [8], but there is no evidence so far to suggest that microglia might receive synaptic input.

In the following discussion, we will, however, summarize the evidence that microglia can express a variety of different classical neurotransmitter receptors that were originally thought to be specific for neurons but in the interim have been widely described in macroglial cells (astrocytes and oligodendrocytes). Synaptic structures are missing on microglia, so how can microglial transmitter receptors be activated? In 1995, Agnati and Fuxe proposed a model of ‘volume transmission’, as opposed to ‘wiring transmission’ 9, 10. In this model, neuroactive substances are not only strictly confined to the synaptic cleft but can also diffuse in the extracellular space and activate extrasynaptic receptors. Indeed, neurons express transmitter receptors not only at the postsynaptic density but also at the presynapse and other regions of the cell. It has been recognized that these extrasynaptic receptors serve many regulatory roles in the neuronal network. This makes it increasingly likely that neurotransmitter receptors are also activated on microglia because of the diffusion of transmitters in the extracellular space.

Section snippets

Ionotropic glutamate receptors (iGluRs) can modulate tumour-necrosis factor α (TNFα) release

Glutamate is the major excitatory neurotransmitter of the CNS, and pertubations in the homeostasis of this transmitter have been reported in neurodegenerative diseases. The main functional iGluRs in cultured rat microglia are mostly AMPA (D,L-α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid)-type GluRs (GluRs 1–3, mainly in the flip form) rather than kainate receptors 11, 12. Whereas glutamate or kainate can trigger TNFα release, AMPA receptor agonists inhibit it; unexpectedly,

Metabotropic glutamate receptors (mGluRs) mediate neurotoxicity and neuroprotection

Microglia express mGluRs, and stimulation by different subtypes of mGluRs can transform microglia into a neuroprotective (via group III mGluRs) or neurotoxic (via group II mGluRs) phenotype (Figure 3) 14, 15, 16, 17. The direct activation of group II mGluRs, particularly mGluR2, induces microglial stress (mitochondrial depolarization and apoptosis) 15, 18 and neurotoxicity [17]. The toxicity of microglial mGluR2 stimulation involves the microglial release of TNFα and FasL (Fas ligand), which

GABAB receptors modulate interleukin (IL) release

GABA (gamma-amino-butyric acid, also known as γ-aminobutyric acid) can act as a neuroprotective agent in addition to playing a well-established role as the main inhibitory neurotransmitter in the CNS. All three principle GABAB receptors are expressed by microglia in situ and in culture [22]. GABAB receptor stimulation leads to the activation of a K+ conductance in cultured microglia and in acute brain slices, and microglial activation leads to an increase in the expression of GABAB receptors in

Purinergic receptors control migration and cytokine release

ATP induces a rapid microglial activation in response to local brain injury in vivo [6], and microglia express a variety of purinergic receptors (Table 1) 23, 24, 25. Purinoreceptors control several properties of microglia, including the motility of their fine processes, the release of cytokines, migration and phagocytosis (Figure 2) 26, 27, 28, 29. ATP triggers a rapid physiological response, the activation of cationic and potassium conductance and an increase in intracellular calcium (for a

Adenosine receptors play a dual role

The neuroprotective effect of adenosine might be linked to the release of neurotrophic factors, such as nerve growth factor (NGF), via the activation of A2a receptors (Figure 3) [44]. However, activation of microglial A2a receptors also induces the expression of COX (cyclooxygenase)-2 mRNA, the synthesis of prostaglandin E2 (PGE2) [45] and the potentiation of nitric oxide (NO) release from activated microglia. This suggests that the specific attenuation of microglial A2a receptors might

Adrenergic, dopmaninergic and cholinergic receptors exhibit anti-inflammatory effects

Functional noradrenergic and dopaminergic receptors modulate membrane currents in microglia in acutely isolated brain slices [48]. Beta-adrenergic agonists inhibit PMA (phorbol 12-myristate 13-acetate)-induced SO production [49] and LPS-induced IL-12p40 release [50] and suppress microglial proliferation (Figure 3) [51]. Stimulation of adrenergic receptors decreases cytokine and NO expression and release 48, 52, 53. Chronic application of dopamine also attenuates LPS-induced NO release but not

Cannabinoid receptors mediate neuroprotection

Activated microglia express CB2 cannabinoid receptors when their expression in the normal brain is very low (for a review, see [59]). Activation of the microglial CB2 receptor stimulates microglial migration [60] and proliferation [61], and the receptor works in concert with the abnormal-cannabidiol-sensitive receptor to modulate microglial migration (Figure 2) [60]. Activation of CB1 mediates inhibition of NO production by rat microglia [62], although the proposed intracellular location of CB1

Opioid receptors on microglia and their involvement in Parkinsońs disease, Alzheimeŕs disease and HIV dementia

Of the three classes of opioid receptors (delta [δ], mu [μ] and kappa [κ]) so far identified, microglia express μ-opioid receptors (MORs) and κ-opioid receptors (KORs) but not δ receptors, and they also express a third, seemingly opioid-receptor-independent pathway for the activity of endogenous opioid-receptor ligands, such as dynophin. MOR3 activation triggers morphological changes and brain-derived neurotrophic factor (BDNF) expression 71, 72 and inhibits microglial chemotaxis and migration,

Neuropeptides can be pro- and anti-inflammatory

Evidence suggests that the tachykinin substance P augments proinflammatory responses in microglia. Microglia can express substance P [81] and its receptor, neurokinin-1 (NK-1), suggesting an autocrine loop for substance P signalling in microglia. Substance P can stimulate chemotaxis at low concentrations of only 10 nM via an NK-1-mediated pathway and activate the transcriptional factor NF-κB [82] and microglial NADPH oxidase; the activation of microglial NADPH leads to the generation of

Conclusion

It is evident that microglia express a variety of neurotransmitter receptors and that these receptors control microglial functions. One could speculate that, during normal brain function, extrasynaptic neurotransmitters signal to microglia that neurons are active and thereby suppress microglial activation. Essentially, all the known functions of microglia are linked to pathology, and this implies that neurotransmitters can influence pathologic processes via microglia. One of the major handicaps

References (95)

  • K. Heese

    Nerve growth factor (NGF) expression in rat microglia is induced by adenosine A2a-receptors

    Neurosci. Lett.

    (1997)
  • J.Y. Lee

    Activation of adenosine A(3) receptor suppresses lipopolysaccharide-induced TNF-alpha production through inhibition of PI13-kinase/Akt and NfkappaB activation in murine BV2 microglial cells

    Neurosci. Lett.

    (2006)
  • K. Färber

    Dopamine and noradrenaline control distinct functions in rodent microglial cells

    Mol. Cell. Neurosci.

    (2005)
  • C.A. Colton et al.

    Inhibition of microglial superoxide anion production by isoproterenol and dexamethasone

    Neurochem. Int.

    (1996)
  • M. Prinz

    β-adrenergic receptor stimulation selectively inhibits IL-12p40 release in microglia

    Brain Res.

    (2001)
  • H. Fujita

    Adrenergic agonists suppress the proliferation of microglia through β2-adrenergic receptor

    Neurosci. Lett.

    (1998)
  • K. Mori

    Effects of norepinephrine on rat cultured microglial cells that express α1, α2, β1 and β2 adrenergic receptors

    Neuropharm.

    (2002)
  • B. Giunta

    Galantamine and nicotine have a synergistic effect on inhibition of microglial activation induced by HIV-1 gp120

    Brain Res. Bull.

    (2004)
  • A. Franklin et al.

    Arachidonylcyclopropylamide increases microglial cell migration through cannabinoid CB2 and abnormal-cannabidiol-sensitive receptors

    Eur. J. Pharmacol.

    (2003)
  • E. Eljaschewitsch

    The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells

    Neuron

    (2006)
  • K. Dobrenis

    Occurrence of the opiate alkaloid-selective mu3 receptor in mammalian microglia, astrocytes and Kupffer cells

    Brain Res.

    (1995)
  • S. Hu

    Morphine induces apoptosis of human microglia and neurons

    Neuropharmacol.

    (2002)
  • C.C. Chao

    U50488 protection against HIV-1-related neurotoxicity: involvement of quinolinic acid suppression

    Neuropharmacol.

    (2000)
  • C.I. Svensson

    Prostaglandin E2 release evoked by intrathecal dynorphin is dependent on spinal p38 mitogen activated protein kinase

    Neuropeptides

    (2005)
  • J.P. Lai

    Detection of substance P and its receptor in human fetal microglia

    Neurosci.

    (2000)
  • M. Noda

    Expression and function of bradykinin receptors in microglia

    Life Sci.

    (2003)
  • K.J. Charles

    GABA B receptor subunit expression in glia

    Mol. Cell. Neurosci.

    (2003)
  • M. Mittelbronn

    Local distribution of microglia in the normal adult human central nervous system differs by up to one order of magnitude

    Acta. Neuropathol. (Berl.).

    (2001)
  • P. del Río-Hortega

    El tercer elemento de los centros nerviosos

    Bol. Soc. Esp. Biol.

    (1919)
  • D. van Rossum et al.

    Microglia

    Metab. Brain Dis.

    (2004)
  • S.U. Kim et al.

    Microglia in health and disease

    J. Neurosci. Res.

    (2005)
  • J.W. Streit

    Microglia as neuroprotective, immunocompetent cells of the CNS

    Glia

    (2002)
  • D. Davalos

    ATP mediates rapid microglial responses to local brain injury in vivo

    Nat. Neurosci.

    (2005)
  • A. Nimmerjahn

    Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo

    Science

    (2005)
  • S.C. Lin et al.

    Synaptic signaling between neurons and glia

    Glia

    (2004)
  • M. Noda

    AMPA-kainate subtype of glutamate receptor in rat cerebral microglia

    J. Neurosci.

    (2000)
  • Y. Hagino

    Heterogeneity and potentiation of AMPA type of glutamate receptors in rat cultured microglia

    Glia

    (2004)
  • M. Gottlieb et al.

    Expression of ionotropic glutamate receptor subunits in glial cells of the hippocampal CA1 area following transient forebrain ischaemia

    J. Cereb. Blood Flow Metab.

    (1997)
  • K. Biber

    Expression and signalling of group I metabotropic glutamate receptors in astrocytes and microglia

    J. Neurochem.

    (1999)
  • D.L. Taylor

    Activation of group II metabotropic glutamate receptors underlies microglial reactivity and neurotoxicity following stimulation with chromogranin A, a peptide up-regulated in Alzheimer's disease

    J. Neurochem.

    (2002)
  • D.L. Taylor

    Activation of microglial group III metabotropic glutamate receptors protects neurons against microglial neurotoxicity

    J. Neurosci.

    (2003)
  • D.L. Taylor

    Stimulation of microglial metabotopic glutamate receptor, mGlu2 triggers TNFα-induced neurotoxicity in concert with microglial derived FasL

    J. Neurosci.

    (2005)
  • P.J. Kingham et al.

    Microglial apoptosis induced by chromogranin A is mediated by a mitochondrial depolarisation and the permeability transition but not by cytochrome c release

    J. Neurochem.

    (2000)
  • P.J. Kingham

    Apoptotic pathways mobilized in microglia and neurones as a consequence of chromogranin A-induced microglial activation

    J. Neurochem.

    (1999)
  • J.P. Pin et al.

    The metabotropic glutamate receptors: structure and functions

    Neurosci. Lett.

    (1995)
  • A.E. Bandrowski

    Baseline glutamate levels affect group I and II mGluRs in layer V pyramidal neurons of rat sensorimotor cortex

    J. Neurophysiol.

    (2003)
  • W. Norenberg

    Characterisation and possible function of adenosine 5′-triphosphate receptors in activated rat microglia

    Br. J. Pharmacol.

    (1994)
  • Cited by (528)

    View all citing articles on Scopus
    View full text